Aredia and Hypercoagulation - a phase IV clinical study of FDA data

Summary:

Hypercoagulation is reported as a side effect among people who take Aredia (pamidronate disodium), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Neurontin, and have Metastases to bone.

The phase IV clinical study analyzes which people have Hypercoagulation when taking Aredia. It is created by eHealthMe based on reports of 15,280 people who have side effects when taking Aredia from the FDA, and is updated regularly.

What is Aredia?

Aredia has active ingredients of pamidronate disodium. It is often used in breast cancer. eHealthMe is studying from 15,364 Aredia users. Check the latest studies of Aredia.

What is Hypercoagulation?

Hypercoagulation (increased tendency for clotting of the blood) is found to be associated with 420 drugs and 534 conditions by eHealthMe. Check the latest studies of Hypercoagulation.

On Jan, 22, 2026

15,280 people reported to have side effects when taking Aredia.
Among them, 47 people (0.31%) have Hypercoagulation.

Among these 47 people:

How long have people been on Aredia when they have Hypercoagulation? *

What is the gender of people who have Hypercoagulation when taking Aredia? *

female: 89.36 %
male: 10.64 %

What is the age of people who have Hypercoagulation when taking Aredia? *

What are other drugs people take besides Aredia? *

What are other side effects people have besides Hypercoagulation? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 41 people, 87.23%
Osteonecrosis Of Jaw (death of bone of jaw): 41 people, 87.23%
Joint Pain: 38 people, 80.85%
Gingival Infection (gum infection): 33 people, 70.21%
Fatigue (feeling of tiredness): 32 people, 68.09%
Osteoporosis (bones weak and more likely to break): 31 people, 65.96%
Pain In Extremity: 31 people, 65.96%
Dyspnea (difficult or laboured breathing): 30 people, 63.83%
Venous Insufficiency (poor circulation of blood caused by damaged or enlarged veins): 30 people, 63.83%
Back Pain: 30 people, 63.83%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 23 people, 48.94%
Pain: 11 people, 23.40%
Oedema (fluid collection in tissue): 11 people, 23.40%
Hypomania (a mild form of mania, marked by elation and hyperactivity): 11 people, 23.40%
Protein S Deficiency: 4 people, 8.51%
Osteoporosis (bones weak and more likely to break): 3 people, 6.38%
Bone Loss: 3 people, 6.38%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 2.13%
Quit Smoking: 1 person, 2.13%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Aredia and have Hypercoagulation?

- Check whether Hypercoagulation is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aredia:

Aredia (15,364 reports)

Browse all side effects of Aredia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercoagulation:

Hypercoagulation (420 drugs)

Browse all the conditions that are associated with Hypercoagulation:

Hypercoagulation (534 conditions)

Drugs similar to Aredia and Hypercoagulation :

How the study uses the data?

The study uses data from the FDA. It is based on pamidronate disodium (the active ingredients of Aredia) and Aredia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.